EUVIMEDEUVIMED entdecken
Crossref

Screening of Oxidative Stress-related Biomarkers and Antioxidant Drugs for Polycystic Ovary Syndrome Based on Bioinformatics and Molecular Docking

Lanhui Chen, Tian Li, Jialiang Xu, Siqi Liao, Haocheng Xu, Kun Li, Deyana Ivanova, Yuewen Si, Xin Zhang, Jianning Zhang, Fangfang Li, Xuemei Chen und 4 weitere

Reproductive Sciences · 2025

DOI: 10.1007/s43032-025-01790-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive Sciences, 2025. Verfasst von Lanhui Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Oxidative Stress, Antioxidants, Molecular Docking Simulation. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality, Science and Technology Project of Chongqing Yuzhong District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder affecting women of reproductive age. Oxidative stress (OS) is suggested to play a significant role in the development of PCOS. Using antioxidants to reduce OS and maintain a healthy balance in the body could be a novel treatment approach for PCOS. This study analyzed transcriptome data from the Gene Expression Omnibus database, focusing on genes associated with OS. By implementing two machine learning algorithms, three OS-related biomarkers-HMOX1, MMP9, and KLF2-were successfully identified. To evaluate the diagnostic potential of these biomarkers, a Logistic regression model was employed. Additionally, granulosa cells were collected from healthy individuals and infertile women with PCOS, and the reliability of HMOX1, MMP9, and KLF2 was verified by quantitative real-time PCR experiments. Furthermore, small molecule drugs targeting proteins encoded by genes HMOX1 and MMP9 were predicted through the Drug Signature Database. Molecular docking of drugs to proteins identified two antioxidants, butein and demethoxycurcumin, as potential candidates for PCOS therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeOxidative StressAntioxidantsMolecular Docking SimulationComputational BiologyFemaleHumansBiomarkersMatrix Metalloproteinase 9Heme Oxygenase-1AdultKruppel-Like Transcription FactorsGranulosa Cells

Stichwörter der Autor:innen

Antioxidant drugsBioinformaticsMolecular dockingOxidative stressPolycystic ovary syndrome

Substanzen

AntioxidantsBiomarkersMatrix Metalloproteinase 9Heme Oxygenase-1HMOX1 protein, humanKruppel-Like Transcription FactorsMMP9 protein, human

Autor:innen und Institutionen

  • Department of Physiology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400016, China.
  • Department of Reproductive Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Joint International Research Laboratory of Reproduction and Development of the Ministry of Education of China, School of Public Health, Chongqing Medical University, Chongqing, 400016, China.
  • Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Biostatistics, School of Public Health, Chongqing Medical University, Chongqing, 400016, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Chongqing Medical University, Chongqing, China. danshi@cqmu.edu.cn.

ORCID-Profile: Meijiao Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing Municipality
  • Science and Technology Project of Chongqing Yuzhong District
  • Science and Technology Research Program of Chongqing Municipal Education Commission
  • Chongqing Maternal and Child Disease Prevention and Control and Public Health Research Center Open Project

Zitieren

APA

Chen, L., Li, T., Xu, J., Liao, S., Xu, H., Li, K., Ivanova, D., Si, Y., Zhang, X., Zhang, J., Li, F., Chen, X., Wang, Y., Xie, B., Shi, D., & Wang, M. (2025). Screening of Oxidative Stress-related Biomarkers and Antioxidant Drugs for Polycystic Ovary Syndrome Based on Bioinformatics and Molecular Docking. Reproductive Sciences. https://doi.org/10.1007/s43032-025-01790-1

Vancouver

Chen L, Li T, Xu J, Liao S, Xu H, Li K, et al. Screening of Oxidative Stress-related Biomarkers and Antioxidant Drugs for Polycystic Ovary Syndrome Based on Bioinformatics and Molecular Docking. Reproductive Sciences. 2025. doi:10.1007/s43032-025-01790-1

BibTeX
@article{Chen2025,
  author = {Chen, Lanhui and Li, Tian and Xu, Jialiang and Liao, Siqi and Xu, Haocheng and Li, Kun and Ivanova, Deyana and Si, Yuewen and Zhang, Xin and Zhang, Jianning and Li, Fangfang and Chen, Xuemei and Wang, Yingxiong and Xie, Biao and Shi, Dan and Wang, Meijiao},
  title = {Screening of Oxidative Stress-related Biomarkers and Antioxidant Drugs for Polycystic Ovary Syndrome Based on Bioinformatics and Molecular Docking},
  journal = {Reproductive Sciences},
  year = {2025},
  doi = {10.1007/s43032-025-01790-1}
}
Kostenlos starten →